A Multinational Phase III Study of CS-8958 (MARVEL)

NCT00803595 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1002

Enrollment

INDUSTRY

Sponsor class

Conditions

Influenza, Human

Interventions

DRUG: CS-8958
DRUG: CS-8958
DRUG: oseltamivir phosphate

Sponsor

Daiichi Sankyo Co., Ltd.